<DOC>
	<DOCNO>NCT01654705</DOCNO>
	<brief_summary>This study compare single-dose oral bioequivalence Pantoprazole sodium 40 mg delay release tablet ( contain 45.1 mg Pantoprazole sodium sesquihydrate equivalent 40 mg Pantoprazole ) OHM Laboratories Inc. USA ( subsidiary Ranbaxy Pharmaceuticals Inc. USA ) PROTONIXÂ® 40 mg delay release tablet ( contain 45.1 mg Pantoprazole sodium sesquihydrate equivalent 40 mg Pantoprazole ) Wyeth Pharmaceuticals Inc. , USA healthy , adult , human , male subject fast conditions.condition .</brief_summary>
	<brief_title>Bioequivalence Study Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study</brief_title>
	<detailed_description>The study open-label , balance , randomize , two-treatment , two-period , two-sequence , single-dose , crossover , bioequivalence fast condition . A washout period 04 day enforce administration study drug period.. At study check-in , subject report clinical site least 36 hour prior Day 1 dosing require stay 24 hour Day 1 dosing . Blood sample collection obtain within 90 minute prior dose ( 0 hour ) dose administration periodic interval 24.00 hour period . A total number blood draw study fifty-four ( 54 ) total volume blood drawn exceed 274 mL . Following overnight fast least 10 hour , single oral dose Pantoprazole sodium delay release tablet 40 mg either test reference drug product administer period study , along 240 mL drink water ambient temperature low light condition supervision train study personnel . Both test reference drug product administer study subject one period</detailed_description>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Volunteers meet follow criterion include study Were age range 1845 year . Were neither overweight underweight height per Life Insurance Corporation India height/weight chart nonmedical case . Had voluntarily give write informed consent participate study . Were normal health determine medical history physical examination subject perform within 21 day prior commencement study . There deviation regard . History known hypersensitivity Pantoprazole , related drug and/or drug . Use alcohol within 48 hour prior admission . Use grapefruit juice grape fruit supplement within 48 hour prior admission . Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination . Subjects investigation ( laboratory test parameter ) was/were outside acceptable limit judge clinically significant investigator . Subjects clinically abnormal ECG Chest Xray . Presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . Subjects clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4 /HPF ) , glucose ( Positive ) Protein ( Positive ) . History serious medical illness include limited gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological hematological disease , diabetes , glaucoma , serious potentially life threaten illness psychiatric illness ( might impair ability provide write informed consent form ) . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . Use regular medication ( OTC prescription ) drug metabolize enzyme modifying medication within 30 day prior Day 1 study . Participation clinical trial within 12 week precede Day 1 study ( except subject dropout/withdrawn previous study prior period I dose ) . Subjects , completion study , would donate /or lose 350 ml blood past 3 month study participation . Subjects problem ( ) comply study protocol . There deviation regard..</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>